Seneca House Advisors Novartis Ag Transaction History

Seneca House Advisors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 10, 2020	SELL	$82.14 - $91.0 $191,632 - $212,303	-2,333 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$80.93 - $91.1 $188,809 - $212,536	2,333 New	2,333 $204,000
Q1 2020 Apr 09, 2020	SELL	$70.67 - $99.01 $157,028 - $220,000	-2,222 Closed	0 $0
Q4 2019 Jan 13, 2020	BUY	$84.35 - $95.37 $187,425 - $211,912	2,222 New	2,222 $210,000
Q3 2018 Oct 19, 2018	SELL	$66.94 - $77.43 $178,060 - $205,963	-2,660 Closed	0 $0
Q2 2018 Jul 23, 2018	BUY	$64.91 - $73.36 $3,570 - $4,034	55 Added 2.11%	2,660 $201,000
Q4 2017 Feb 20, 2018	BUY	$72.33 - $77.64 $188,419 - $202,252	2,605	2,605 $219,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Seneca House Advisors, based on Form 13F filings with the SEC.

Stay updated on Seneca House Advisors with notifications on news.